NeoGenomics (STU:NG9) Beginning Cash Position : €319.9 Mil (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is NeoGenomics Beginning Cash Position?

NeoGenomics's Beginning Cash Position for the quarter that ended in Sep. 2024 was €319.9 Mil.

NeoGenomics's quarterly Beginning Cash Position declined from Mar. 2024 (€315.1 Mil) to Jun. 2024 (€308.3 Mil) but then increased from Jun. 2024 (€308.3 Mil) to Sep. 2024 (€319.9 Mil).

NeoGenomics's annual Beginning Cash Position increased from Dec. 2021 (€221.8 Mil) to Dec. 2022 (€299.1 Mil) but then declined from Dec. 2022 (€299.1 Mil) to Dec. 2023 (€241.3 Mil).

NeoGenomics Beginning Cash Position Historical Data

The historical data trend for NeoGenomics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoGenomics Beginning Cash Position Chart

NeoGenomics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

8.83

142.22

221.81

299.08

241.34

NeoGenomics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Beginning Cash Position	Get a 7-Day Free Trial															270.86	280.82	315.09	308.35	319.93

NeoGenomics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

NeoGenomics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of NeoGenomics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoGenomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » NeoGenomics Inc (STU:NG9) » Definitions » Beginning Cash Position

Comparable Companies

TWST MYGN CDNA VCYT OPK NEOG CSTL SHC GRAL FLGT TMO DHR XSWX:LONN A IQV IDXX MTD ILMN WAT NTRA

Traded in Other Exchanges

NEO:USA NG9:Germany

Address

9490 NeoGenomics Way, Fort Myers, FL, USA, 33912

Website

https://www.neogenomics.com

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

NeoGenomics Headlines

No Headlines